5 filings analyzed. Top movers: BioXcel Therapeutics, Inc., KALA BIO, Inc., Netcapital Inc., VNET Group, Inc., BOXABL Inc..
8-K
BioXcel Therapeutics, Inc.
BioXcel Therapeutics filed an 8-K on August 28, 2026 disclosing Item 1.01 (Material Definitive Agreement) and Item 1.03 (Bankruptcy or Receivership). The filing document itself does not contain the specific terms, counterparties, dollar amounts, or dates of the agreement or bankruptcy proceeding—only the section headers are listed. Critical details required to assess impact are absent from this filing extract.
▼ Likely negative
· significance 92 · 8-K Agent
8-K
KALA BIO, Inc.
KALA BIO filed Form 8-K on 2026-08-28 reporting Item 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard, with transfer of listing mentioned. No specific dollar amounts, counterparties, or remediation details are disclosed in the header/metadata provided. The filing indicates the company has violated exchange continued listing requirements.
▼ Likely negative
· significance 92 · 8-K Agent
8-K
Netcapital Inc.
On August 24, 2026, Netcapital received a delinquency notice from Nasdaq for failing to timely file its Form 10-K for fiscal year ended April 30, 2026. The company has 60 days (until October 23, 2026) to submit a compliance plan, with potential for up to 180 additional days to file the 10-K. No immediate trading suspension has occurred, but failure to regain compliance could result in delisting.
▼ Likely negative
· significance 87 · 8-K Agent
SCHEDULE 13D
VNET Group, Inc.
Shandong Hi-Speed Holdings Group Limited (SDHG), which owns VNET Group Inc. via two BVI entities (Success Flow International Investment Limited and Choice Faith Group Holdings Limited), agreed to sell 650,424,192 Class A Ordinary Shares to PJ Millennium I Limited and PJ Millennium II Limited for a total purchase price of $942,182,804 (at $1.4486 per share). Closing is contingent on SDHG shareholder approval. The transaction includes a $282.7M deposit (30% of purchase price), tranched closing rights, registration and investor rights for the purchasers, and termination fees ranging from 30-100% of the deposit under various circumstances.
— Neutral
· significance 72 · Ownership Agent
8-K
BOXABL Inc.
On August 25, 2026, Boxabl executed a Product Purchase Agreement with LC Vegas Acquisitions, LLC (buyer), a Chicago-based entity, to purchase up to an unspecified number of Boxabl Casita factory-built housing units. Under a concurrent First Amendment, Boxabl will award the buyer Class A common stock worth: $1M for deposits of $10M–$19.999M; $2M for deposits of $20M–$29.999M; or $3M for deposits of $30M+. The number of shares issued is determined by dividing the incentive amount by the VWAP on the closing date, subject to a 4.99% beneficial ownership cap (9.99% if elected by buyer). Share certificates will bear restricted-securities legends; Boxabl must file a registration statement within 120 days of the Balance Due payment and make it effective within 180 days. Specific unit quantities, pricing, and deposit amounts are redacted in Exhibit A.
▲ Likely positive
· significance 62 · 8-K Agent
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.